KR100806412B1 - 전기방사 약제학적 조성물 - Google Patents
전기방사 약제학적 조성물 Download PDFInfo
- Publication number
- KR100806412B1 KR100806412B1 KR1020027009477A KR20027009477A KR100806412B1 KR 100806412 B1 KR100806412 B1 KR 100806412B1 KR 1020027009477 A KR1020027009477 A KR 1020027009477A KR 20027009477 A KR20027009477 A KR 20027009477A KR 100806412 B1 KR100806412 B1 KR 100806412B1
- Authority
- KR
- South Korea
- Prior art keywords
- poly
- active ingredient
- composition
- acid
- water
- Prior art date
Links
Images
Classifications
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0015—Electro-spinning characterised by the initial state of the material
- D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
- D01D5/0038—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion the fibre formed by solvent evaporation, i.e. dry electro-spinning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0015—Electro-spinning characterised by the initial state of the material
- D01D5/0023—Electro-spinning characterised by the initial state of the material the material being a polymer melt
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F1/00—General methods for the manufacture of artificial filaments or the like
- D01F1/02—Addition of substances to the spinning solution or to the melt
- D01F1/10—Other agents for modifying properties
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Textile Engineering (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Mechanical Engineering (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Emergency Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Manufacturing & Machinery (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17868200P | 2000-01-28 | 2000-01-28 | |
US60/178,682 | 2000-01-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20020082212A KR20020082212A (ko) | 2002-10-30 |
KR100806412B1 true KR100806412B1 (ko) | 2008-02-21 |
Family
ID=22653497
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020027009477A KR100806412B1 (ko) | 2000-01-28 | 2001-01-25 | 전기방사 약제학적 조성물 |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1251829A4 (de) |
JP (1) | JP2003521493A (de) |
KR (1) | KR100806412B1 (de) |
CN (1) | CN1223340C (de) |
AR (1) | AR028204A1 (de) |
AU (1) | AU772830B2 (de) |
BR (1) | BR0107869A (de) |
CA (1) | CA2396640A1 (de) |
HU (1) | HUP0301130A3 (de) |
IL (1) | IL150642A0 (de) |
MX (1) | MXPA02007298A (de) |
MY (1) | MY129356A (de) |
NO (1) | NO20023338L (de) |
NZ (1) | NZ519992A (de) |
PL (1) | PL356924A1 (de) |
TW (1) | TWI289061B (de) |
WO (1) | WO2001054667A1 (de) |
ZA (1) | ZA200205989B (de) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101454360B1 (ko) | 2012-08-31 | 2014-10-24 | 서울대학교산학협력단 | 파에도닥틸룸 트리코르누툼 추출물을 함유하는 젤라틴 나노섬유 지지체 및 이를 이용한 창상피복재 |
WO2017130141A1 (en) * | 2016-01-27 | 2017-08-03 | Instar Technologies A.S. | Oromucosal nanofiber carriers for therapeutic treatment |
US11771648B2 (en) | 2011-01-17 | 2023-10-03 | Instar Technologies A.S. | Carrier for oromucosal administration of physiologically active substances |
Families Citing this family (112)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9910505D0 (en) | 1999-05-06 | 1999-07-07 | Electrosols Ltd | A method and apparatus for manufacturing consumable tablets |
EP1333808B1 (de) * | 2000-10-18 | 2012-07-25 | Virginia Commonwealth University Intellectual Property Foundation | Elektroprozesszusammensetzung für die verabreichung von heilmitteln oder die einschliessung von zellen |
DE60135019D1 (de) * | 2000-11-17 | 2008-09-04 | Univ Virginia Commonwealth | Elektroverarbeitetes kollagen |
JP2010163435A (ja) * | 2000-11-17 | 2010-07-29 | Virginia Commonwealth Univ Intellectual Property Foundation | 電気処理されたコラーゲン |
WO2002074191A2 (en) * | 2001-03-20 | 2002-09-26 | Nicast Ltd. | Portable electrospinning device |
US6685956B2 (en) * | 2001-05-16 | 2004-02-03 | The Research Foundation At State University Of New York | Biodegradable and/or bioabsorbable fibrous articles and methods for using the articles for medical applications |
GB0123951D0 (en) * | 2001-10-05 | 2001-11-28 | Glaxo Group Ltd | Therapies for treating respiratory diseases |
WO2003063833A1 (en) | 2002-02-01 | 2003-08-07 | Pfizer Products Inc. | Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials |
KR100549140B1 (ko) * | 2002-03-26 | 2006-02-03 | 이 아이 듀폰 디 네모아 앤드 캄파니 | 일렉트로-브로운 방사법에 의한 초극세 나노섬유 웹제조방법 |
US8367570B2 (en) | 2002-04-04 | 2013-02-05 | The University Of Akron | Mechanically strong absorbent non-woven fibrous mats |
KR101130879B1 (ko) | 2002-04-04 | 2012-03-28 | 더 유니버시티 오브 아크론 | 부직포 섬유 집합체 |
AU2003221677A1 (en) * | 2002-04-11 | 2003-10-27 | Secant Medical, Inc. | Covering process using electrospinning of very small fibers |
US20060083784A1 (en) * | 2002-08-07 | 2006-04-20 | Smithkline Beecham Corporation | Amorphous pharmaceutical compositions |
TW200410714A (en) * | 2002-08-07 | 2004-07-01 | Smithkline Beecham Corp | Electrospun amorphous pharmaceutical compositions |
WO2004062697A2 (en) | 2003-01-07 | 2004-07-29 | Tufts University | Silk fibroin materials and use thereof |
JP2007501218A (ja) | 2003-08-04 | 2007-01-25 | ファイザー・プロダクツ・インク | 非晶質薬物の吸着物および親油性ミクロ相形成物質の医薬組成物 |
US8974823B2 (en) | 2003-12-31 | 2015-03-10 | Bend Research, Inc. | Solid compositions of low-solubility drugs and poloxamers |
JP4526851B2 (ja) * | 2004-03-31 | 2010-08-18 | 明彦 谷岡 | 多糖類のナノスケールの繊維および成形体 |
WO2006006746A1 (en) * | 2004-07-09 | 2006-01-19 | Hak-Yong Kim | Polymer particles, and a method for manufacturing the same |
CN100577720C (zh) * | 2005-03-21 | 2010-01-06 | 中国科学院化学研究所 | 可生物降解及吸收的聚合物纳米纤维膜材料及制法和用途 |
JP2006299459A (ja) * | 2005-04-20 | 2006-11-02 | National Institute For Materials Science | 生分解性高分子不織布チューブの製造方法 |
CN1300393C (zh) * | 2005-07-01 | 2007-02-14 | 中国科学院长春应用化学研究所 | 超细纤维药物剂型的乳液电纺丝制备方法 |
WO2007011030A1 (ja) * | 2005-07-21 | 2007-01-25 | National Institute For Materials Science | 薬物吸入デバイス |
JP4787585B2 (ja) * | 2005-09-29 | 2011-10-05 | 帝人株式会社 | 静電紡糸法による繊維構造体の製造方法 |
CN100556399C (zh) * | 2005-12-23 | 2009-11-04 | 中国科学院广州化学研究所 | 一种肠靶向型药物控释纤维及其制备方法 |
US8367112B2 (en) * | 2006-02-28 | 2013-02-05 | Alkermes Pharma Ireland Limited | Nanoparticulate carverdilol formulations |
KR100824719B1 (ko) * | 2006-09-04 | 2008-04-24 | 주식회사 아모메디 | 전분함유 나노섬유 부직포로 이루어진 생분해성 식품포장재 및 그 제조방법 |
WO2009120365A2 (en) | 2008-03-27 | 2009-10-01 | Agigma, Inc. | Methods and compositions for the delivery of agents |
EP2666457B1 (de) | 2008-04-16 | 2020-06-17 | The Procter & Gamble Company | Verfahren zur Herstellung einer nichtschäumenden Körperpflegezusammensetzung in Form eines löslichen festen Schaums |
JP2011530661A (ja) | 2008-08-08 | 2011-12-22 | ビーエーエスエフ ソシエタス・ヨーロピア | 活性成分の制御放出を伴う有効成分含有繊維表面構造体、その使用、およびその生産のための方法 |
JP2011530491A (ja) | 2008-08-08 | 2011-12-22 | ビーエーエスエフ ソシエタス・ヨーロピア | バイオポリマーに基づいた活性物質含有連続繊維層、その使用、およびその生産のための方法 |
CN101721751B (zh) * | 2008-10-10 | 2013-01-02 | 张阳德 | 负载了缓释细胞生长因子的具有内核的中空二氧化硅球的人体组织工程支架及其制法和用途 |
US20100291182A1 (en) * | 2009-01-21 | 2010-11-18 | Arsenal Medical, Inc. | Drug-Loaded Fibers |
KR101065255B1 (ko) * | 2009-02-13 | 2011-09-16 | 김근형 | 생분해성 폴리머의 전기방사를 이용한 신규 약물 전달 시스템 |
CN101559242B (zh) * | 2009-05-22 | 2015-07-29 | 广州迈普再生医学科技有限公司 | 一种可同时作为药物缓释体系的纳米人工硬脑膜及其制备方法 |
WO2011029777A1 (de) | 2009-09-11 | 2011-03-17 | Basf Se | Verfahren zur herstellung von beschichteten polymerfasern |
US9295859B2 (en) | 2009-12-08 | 2016-03-29 | The Procter & Gamble Company | Porous, dissolvable solid substrate and surface resident coating comprising matrix microspheres |
EP2536386A1 (de) | 2010-02-16 | 2012-12-26 | The Procter & Gamble Company | Poröses, lösliches feststoffsubstrat und oberflächenhaftende beschichtung mit einem zink-pyrithion |
CN101816627B (zh) * | 2010-04-16 | 2012-03-07 | 浙江大学 | 一种协同治疗型多物质缓释滴眼剂及制备方法 |
EP2588288B1 (de) | 2010-07-02 | 2015-10-28 | The Procter and Gamble Company | Verfahren zur herstellung von folien aus vliesfaserbahnen |
MX2012015174A (es) | 2010-07-02 | 2013-05-09 | Procter & Gamble | Filamentos que comprenden un agente activo, tramas de tela no tejida y métodos para elaborarlos. |
CN102959150B (zh) * | 2010-07-02 | 2016-08-03 | 宝洁公司 | 包含可摄取活性剂的长丝、非织造纤维网及其制备方法 |
MX2012015187A (es) | 2010-07-02 | 2013-05-09 | Procter & Gamble | Metodo para suministrar un agente activo. |
MX345025B (es) | 2010-07-02 | 2017-01-12 | Procter & Gamble | Producto detergente. |
BR122019015741B1 (pt) | 2010-07-02 | 2021-12-21 | The Procter & Gamble Company | Artigo de estrutura de manta fibrosa dissolvível que compreende agentes ativos |
WO2012003300A2 (en) * | 2010-07-02 | 2012-01-05 | The Procter & Gamble Company | Filaments comprising a non-perfume active agent nonwoven webs and methods for making same |
US20180163325A1 (en) | 2016-12-09 | 2018-06-14 | Robert Wayne Glenn, Jr. | Dissolvable fibrous web structure article comprising active agents |
MX2013000201A (es) * | 2010-07-02 | 2013-08-21 | Procter & Gamble | Metodos para suministrar un activo de atencion sanitaria por medio de administrar articulos de cuidado personal que comprenden un filamento. |
CN101915797B (zh) * | 2010-07-27 | 2011-09-28 | 北京师范大学 | 一种静电纺丝固定化漆酶电极的制备方法 |
WO2012070028A1 (en) * | 2010-11-26 | 2012-05-31 | University Of The Witwatersrand, Johannesburg | A pharmaceutical dosage form |
WO2012084441A1 (en) | 2010-12-22 | 2012-06-28 | Unilever Nv | Compositions in the form of fibres |
WO2012084427A1 (en) | 2010-12-22 | 2012-06-28 | Unilever Nv | Compositions comprising structured non-aqueous liquid phase |
CN102251317B (zh) * | 2011-05-18 | 2013-01-16 | 东华大学 | 一种药物释放可控的电纺纤维的制备方法 |
WO2013124869A2 (en) * | 2012-02-21 | 2013-08-29 | Amrita Vishwa Vidyapeetham University | The art, method,manner process and system of fibrous bio-degradable polymeric wafers for the local delivery of therapeutic agents in combinations |
CN102631715A (zh) * | 2012-05-04 | 2012-08-15 | 江南大学 | 一种抗凝血纳米纤维膜的制备方法 |
CN102670483B (zh) * | 2012-05-09 | 2014-04-02 | 上海交通大学 | 一种用于高血脂症治疗的静电纺丝纤维膜制剂及其制备方法 |
CN102697727B (zh) * | 2012-06-12 | 2014-01-08 | 东华大学 | 一种利用静电纺丝技术制备自组装酮洛芬脂质体的方法 |
ES2743761T3 (es) | 2012-10-12 | 2020-02-20 | Procter & Gamble | Composición para la higiene personal en forma de artículo soluble |
WO2014131376A1 (en) * | 2013-02-26 | 2014-09-04 | Elmarco S.R.O. | Electrospun nanofibers comprising pharmaceutically active agents |
CN115137841A (zh) | 2013-03-12 | 2022-10-04 | 纳诺莱尔有限公司 | 纳米纤维和生物活性组合物及相关方法 |
EP2813212A1 (de) | 2013-06-10 | 2014-12-17 | Zentiva, a.s. | Arzneimittel-Formulierung, einsetzend API in Nanofasern |
US10202636B2 (en) * | 2013-12-24 | 2019-02-12 | General Electric Company | Electrospun fibers for protein stabilization and storage |
EP3134184B1 (de) | 2014-04-22 | 2024-04-10 | The Procter & Gamble Company | Zusammensetzungen in form von löslichen festen strukturen |
US9867762B2 (en) | 2014-05-05 | 2018-01-16 | The Procter & Gamble Company | Consumer product comprising a porous dissolvable solid structure and silicone conditioning agent coating |
US9937111B2 (en) | 2014-05-05 | 2018-04-10 | The Procter & Gamble Company | Consumer product comprising a fibrous web solid structure with a silicone conditioning agent coating |
US9827173B2 (en) | 2014-05-05 | 2017-11-28 | The Procter & Gamble Company | Porous dissolvable solid structure with two benefit agents and methods of forming an aqueous treatment liquor therefrom |
US9861558B2 (en) | 2014-05-05 | 2018-01-09 | The Procter & Gamble Company | Methods of forming an aqueous treatment liquor by dissolving a porous solid with a benefit agent coating |
US9861559B2 (en) | 2014-05-05 | 2018-01-09 | The Procter & Gamble Company | Consumer product comprising a porous, dissolvable, fibrous web solid structure with a silicone coating |
US9877899B2 (en) | 2014-05-05 | 2018-01-30 | The Procter & Gamble Company | Consumer product comprising a fibrous web structure with a silicone conditioning agent coating |
BR112016028961B1 (pt) * | 2014-06-10 | 2023-04-11 | Afyx Therapeutics A/S | Composição compreendendo fibras eletrotorcidas, seu método de preparação e kit |
CN105362269A (zh) * | 2014-09-01 | 2016-03-02 | 天津药物研究院 | 一种含蔗糖的罗氟司特片及其制备方法 |
EP3278791A4 (de) * | 2015-03-31 | 2018-10-24 | Orthorebirth Co., Ltd. | Verfahren zur herstellung von biologisch abbaubarem arzneimittelhaltigen fasermaterial durch elektrospinnen |
CN108025477A (zh) * | 2015-07-07 | 2018-05-11 | 新加坡保健服务集团 | 聚合物产品及其制备 |
CN105327357B (zh) * | 2015-10-14 | 2019-01-11 | 北京科技大学 | 一种邻苯二酚修饰的透明质酸的载药系统及其制备方法 |
JP6606279B2 (ja) * | 2015-11-19 | 2019-11-13 | エーエフワイエックス・セラピューティクス・エー/エス | 適用部位における滞留時間が改善された、電気流体力学的に得られた繊維を含む医薬組成物 |
CN105727358B (zh) * | 2016-02-23 | 2019-01-22 | 广西易得佳医疗器械有限公司 | 载药生物高分子复合纳米纤维膜及其制备方法 |
CN105663025A (zh) * | 2016-02-29 | 2016-06-15 | 浙江工业大学 | 一种含药微丝及其制备方法 |
MX2019008258A (es) | 2017-01-23 | 2020-01-27 | Afyx Therapeutics As | Metodo para la fabricacion de un producto de dos capas basado en fibras electrohiladas. |
BR112019014732A2 (pt) | 2017-01-23 | 2020-03-10 | Afyx Therapeutics A/S | Método para a preparação de fibras eletrofiadas com um alto teor de uma substância bioadesiva |
CN110167639B (zh) | 2017-01-27 | 2022-10-14 | 宝洁公司 | 呈包含泡腾型附聚颗粒的可溶性固体结构形式的组合物 |
EP4245296A3 (de) | 2017-01-27 | 2023-12-06 | The Procter & Gamble Company | Zubereitungen in form von löslichen festen strukturen |
JP6923673B2 (ja) | 2017-05-16 | 2021-08-25 | ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company | 溶解性固形構造体の形態のコンディショニングヘアケア組成物 |
CN107447366A (zh) * | 2017-08-03 | 2017-12-08 | 东华大学 | 一种pH敏感载药缓释纳米纤维膜及其制备方法和应用 |
JP7127135B2 (ja) | 2018-01-26 | 2022-08-29 | ザ プロクター アンド ギャンブル カンパニー | 水溶性物品及び関連プロセス |
CN111556891B (zh) | 2018-01-26 | 2021-11-05 | 宝洁公司 | 包含酶的水溶性单位剂量制品 |
US11053466B2 (en) | 2018-01-26 | 2021-07-06 | The Procter & Gamble Company | Water-soluble unit dose articles comprising perfume |
KR20200085891A (ko) | 2018-01-26 | 2020-07-15 | 더 프록터 앤드 갬블 캄파니 | 향료를 포함하는 수용성 단위 용량 물품 |
WO2019168829A1 (en) | 2018-02-27 | 2019-09-06 | The Procter & Gamble Company | A consumer product comprising a flat package containing unit dose articles |
JP7121944B2 (ja) * | 2018-05-07 | 2022-08-19 | 国立大学法人信州大学 | ナノ繊維及びその製造方法 |
JP1639110S (de) | 2018-07-16 | 2019-08-13 | ||
US10982176B2 (en) | 2018-07-27 | 2021-04-20 | The Procter & Gamble Company | Process of laundering fabrics using a water-soluble unit dose article |
US11666514B2 (en) | 2018-09-21 | 2023-06-06 | The Procter & Gamble Company | Fibrous structures containing polymer matrix particles with perfume ingredients |
CN113748195B (zh) | 2019-01-28 | 2024-01-19 | 宝洁公司 | 可回收利用的、可再生的或可生物降解的包装 |
EP3712237A1 (de) | 2019-03-19 | 2020-09-23 | The Procter & Gamble Company | Faserige wasserlösliche einmal-dosierartikel mit wasserlöslichen faserstrukturen |
WO2020264574A1 (en) | 2019-06-28 | 2020-12-30 | The Procter & Gamble Company | Dissolvable solid fibrous articles containing anionic surfactants |
CN114025738A (zh) | 2019-07-03 | 2022-02-08 | 宝洁公司 | 包含阳离子表面活性剂和可溶性酸的纤维结构 |
USD939359S1 (en) | 2019-10-01 | 2021-12-28 | The Procter And Gamble Plaza | Packaging for a single dose personal care product |
KR20220062613A (ko) | 2019-10-14 | 2022-05-17 | 더 프록터 앤드 갬블 캄파니 | 고체 물품을 함유하는 생분해성 및/또는 가정 퇴비화가능 사셰 |
EP4061320A1 (de) | 2019-11-20 | 2022-09-28 | The Procter & Gamble Company | Poröse lösliche feste struktur |
CN114929182B (zh) | 2019-12-01 | 2024-05-28 | 宝洁公司 | 具有含有苯甲酸钠和二醇和/或甘油酯的防腐体系的毛发调理剂组合物 |
USD941051S1 (en) | 2020-03-20 | 2022-01-18 | The Procter And Gamble Company | Shower hanger |
USD962050S1 (en) | 2020-03-20 | 2022-08-30 | The Procter And Gamble Company | Primary package for a solid, single dose beauty care composition |
USD965440S1 (en) | 2020-06-29 | 2022-10-04 | The Procter And Gamble Company | Package |
MX2023001042A (es) | 2020-07-31 | 2023-02-16 | Procter & Gamble | Bolsa fibrosa soluble en agua que contiene granulos para el cuidado del cabello. |
WO2022036354A1 (en) | 2020-08-11 | 2022-02-17 | The Procter & Gamble Company | Low viscosity hair conditioner compositions containing brassicyl valinate esylate |
CA3188274A1 (en) | 2020-08-11 | 2022-02-17 | The Procter & Gamble Company | Clean rinse hair conditioner compositions containing brassicyl valinate esylate |
CN116018123A (zh) | 2020-08-11 | 2023-04-25 | 宝洁公司 | 含有芸苔油醇缬氨酸酯乙磺酸盐的保湿毛发调理剂组合物 |
MX2023005792A (es) | 2020-12-01 | 2023-05-29 | Procter & Gamble | Composiciones acuosas acondicionadoras de cabello que contienen activos anticaspa solubilizados. |
CN113041230B (zh) * | 2021-03-23 | 2022-06-24 | 浙江尖峰健康科技有限公司 | 一种软胶囊的囊皮及由其制备的软胶囊 |
KR102653460B1 (ko) * | 2021-09-01 | 2024-03-29 | 한남대학교 산학협력단 | 콜라겐과 레시틴을 포함하는 분해도 조절이 가능한 스타치 나노섬유의 제조방법 |
WO2023145886A1 (ja) * | 2022-01-31 | 2023-08-03 | 三菱ケミカル株式会社 | ナノファイバー |
CN114808184A (zh) * | 2022-03-11 | 2022-07-29 | 深圳市法鑫忠信新材料有限公司 | 一种长效驱蚊的静电纺丝纤维及其制备方法和应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5567439A (en) | 1994-06-14 | 1996-10-22 | Fuisz Technologies Ltd. | Delivery of controlled-release systems(s) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1527592A (en) * | 1974-08-05 | 1978-10-04 | Ici Ltd | Wound dressing |
US4855326A (en) * | 1987-04-20 | 1989-08-08 | Fuisz Pharmaceutical Ltd. | Rapidly dissoluble medicinal dosage unit and method of manufacture |
US5736152A (en) * | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
US5869098A (en) * | 1997-08-20 | 1999-02-09 | Fuisz Technologies Ltd. | Fast-dissolving comestible units formed under high-speed/high-pressure conditions |
US5980941A (en) * | 1997-08-20 | 1999-11-09 | Fuisz Technologies Ltd. | Self-binding shearform compositions |
US6753454B1 (en) * | 1999-10-08 | 2004-06-22 | The University Of Akron | Electrospun fibers and an apparatus therefor |
-
2001
- 2001-01-25 CN CNB018042422A patent/CN1223340C/zh not_active Expired - Fee Related
- 2001-01-25 MX MXPA02007298A patent/MXPA02007298A/es active IP Right Grant
- 2001-01-25 NZ NZ519992A patent/NZ519992A/en not_active IP Right Cessation
- 2001-01-25 KR KR1020027009477A patent/KR100806412B1/ko not_active IP Right Cessation
- 2001-01-25 IL IL15064201A patent/IL150642A0/xx unknown
- 2001-01-25 HU HU0301130A patent/HUP0301130A3/hu unknown
- 2001-01-25 EP EP01903299A patent/EP1251829A4/de not_active Withdrawn
- 2001-01-25 JP JP2001555646A patent/JP2003521493A/ja active Pending
- 2001-01-25 CA CA002396640A patent/CA2396640A1/en not_active Abandoned
- 2001-01-25 AU AU31134/01A patent/AU772830B2/en not_active Ceased
- 2001-01-25 PL PL01356924A patent/PL356924A1/xx not_active Application Discontinuation
- 2001-01-25 BR BR0107869-0A patent/BR0107869A/pt not_active Application Discontinuation
- 2001-01-25 WO PCT/US2001/002399 patent/WO2001054667A1/en active IP Right Grant
- 2001-01-26 AR ARP010100354A patent/AR028204A1/es unknown
- 2001-01-26 MY MYPI20010355A patent/MY129356A/en unknown
- 2001-02-07 TW TW090101371A patent/TWI289061B/zh not_active IP Right Cessation
-
2002
- 2002-07-11 NO NO20023338A patent/NO20023338L/no not_active Application Discontinuation
- 2002-07-26 ZA ZA200205989A patent/ZA200205989B/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5567439A (en) | 1994-06-14 | 1996-10-22 | Fuisz Technologies Ltd. | Delivery of controlled-release systems(s) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11771648B2 (en) | 2011-01-17 | 2023-10-03 | Instar Technologies A.S. | Carrier for oromucosal administration of physiologically active substances |
KR101454360B1 (ko) | 2012-08-31 | 2014-10-24 | 서울대학교산학협력단 | 파에도닥틸룸 트리코르누툼 추출물을 함유하는 젤라틴 나노섬유 지지체 및 이를 이용한 창상피복재 |
WO2017130141A1 (en) * | 2016-01-27 | 2017-08-03 | Instar Technologies A.S. | Oromucosal nanofiber carriers for therapeutic treatment |
Also Published As
Publication number | Publication date |
---|---|
KR20020082212A (ko) | 2002-10-30 |
NZ519992A (en) | 2004-04-30 |
ZA200205989B (en) | 2003-02-03 |
JP2003521493A (ja) | 2003-07-15 |
AU3113401A (en) | 2001-08-07 |
AR028204A1 (es) | 2003-04-30 |
TWI289061B (en) | 2007-11-01 |
PL356924A1 (en) | 2004-07-12 |
HUP0301130A3 (en) | 2006-07-28 |
NO20023338L (no) | 2002-09-03 |
BR0107869A (pt) | 2002-11-05 |
EP1251829A1 (de) | 2002-10-30 |
MXPA02007298A (es) | 2002-12-09 |
CN1223340C (zh) | 2005-10-19 |
IL150642A0 (en) | 2003-02-12 |
HUP0301130A2 (hu) | 2003-09-29 |
CN1396823A (zh) | 2003-02-12 |
CA2396640A1 (en) | 2001-08-02 |
AU772830B2 (en) | 2004-05-06 |
NO20023338D0 (no) | 2002-07-11 |
WO2001054667A1 (en) | 2001-08-02 |
EP1251829A4 (de) | 2009-05-06 |
MY129356A (en) | 2007-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100806412B1 (ko) | 전기방사 약제학적 조성물 | |
US20030017208A1 (en) | Electrospun pharmaceutical compositions | |
AU2003258120B2 (en) | Electrospun amorphous pharmaceutical compositions | |
US20060083784A1 (en) | Amorphous pharmaceutical compositions | |
Wang et al. | Electrospun medicated shellac nanofibers for colon-targeted drug delivery | |
Jiang et al. | Electrospun drug-loaded core–sheath PVP/zein nanofibers for biphasic drug release | |
Ignatious et al. | Electrospun nanofibers in oral drug delivery | |
AU2004202461B2 (en) | Electrospun pharmaceutical compositions | |
Shams et al. | Core/shell microencapsulation of indomethacin/paracetamol by co-axial electrohydrodynamic atomization | |
Vass et al. | Continuous drying of a protein-type drug using scaled-up fiber formation with HP-β-CD matrix resulting in a directly compressible powder for tableting | |
Malkawi et al. | Current trends on solid dispersions: past, present, and future | |
Shadambikar et al. | Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology | |
Bindhani et al. | Recent approaches of solid dispersion: a new concept toward oral bioavailability | |
Pisani et al. | Tableted hydrophilic electrospun nanofibers to promote meloxicam dissolution rate | |
Wang et al. | Reduced burst release and enhanced Oral bioavailability in Shikimic acid–loaded Polylactic acid submicron particles by coaxial electrospray | |
CN114748428A (zh) | 一种高载药量的盐酸卡利拉嗪长效缓释微球及其制备方法 | |
Thakkar et al. | Electrospray particles as drug delivery systems: concepts, strategies, and applications | |
EP3494970A2 (de) | Schwerlösliche therapeutika der bcs-klasse ii oder iv, suspendiert in der flüssigen formulierung und/oder in der endgültigen nanofaserstruktur | |
Patel et al. | EVALUATION OF CRITICAL MATERIAL ATRRIBUTES (CMA) AND CRITICAL PROCESS PARAMETERS (CPP) FOR FORMULATION OF PLGA BASED MICROSPHERE BY COACERVATION METHOD | |
TUTOR et al. | NOVEL DRUG DELIVERY SYSTEMS FOR TREATMENT-RESISTANT SCHIZOPHRENIA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120131 Year of fee payment: 5 |
|
LAPS | Lapse due to unpaid annual fee |